Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "sandoz inc"

Apricus Announces Plans To Further Commercialize Its ED Drug Vitaros In 2015

Apricus announces launch of erectile dysfunction drug in Belgi...

Apricus Biosciences, Inc., a biopharmaceutical company, has announced the launch of Vytaros, for treatment of erectile dysfunction, in Belgium by the Sandoz Division of the Novartis Group of Companies. Apricus' novel topical on-demand treatment for ..., 1 month ago

2 images for "sandoz inc"

Talk Radio News Service, 2 months ago
Reuters UK, 2 months ago
Bidness Etc

Phase 3 Data Shows Sandoz, Inc.'s Investigational Biosimilar Filgrastim Has Similar Safety And Efficacy As Amgen's NEUPOGEN??

Pivotal PIONEER study compared safety and efficacy of the two compounds in the prevention of neutropenia in patients with breast cancer PIONEER data supported filing for biosimilar filgrastim in the US The abstract of the study results is ...
 BioSpace2 weeks ago Novartis AG Copy Of Amgen Cancer Drug Shows Similar Efficacy  BioSpace2 weeks ago Novartis AG (NVS) Copy Of Amgen (AMGN) Cancer Drug Shows Similar Efficacy 12/8/2014  ClinicSpace2 weeks ago Novartis : Phase III data shows Sandoz' investigational biosimilar filgrastim has similar safety and efficacy as Amgen's NEUPOGEN┬«  4 Traders2 weeks ago

Sandoz receives marketing authorizations for asthma inhaler in Baltics

Sandoz Inc. has received marketing authorizations from the pharmaceutical regulatory authorities in Estonia, Latvia and Lithuania for AirFluSal Forspiro, a new inhaler for patients with asthma and/or chronic obstructive pulmonary disease, or COPD.
 Individual.com1 month ago

Sandoz loses bid to shield psoriasis drug

By Dec 5 (Reuters) - The top U.S. patent appeals court has upheld the dismissal of a lawsuit brought by Sandoz Inc that sought to shield its planned version of Amgen Inc's psoriasis and arthritis drug Enbrel from patent lawsuits. The ruling, handed ...
 Sharenet3 weeks ago

Teva Pharmaceuticals USA, Inc v Sandoz, Inc

the Supreme Court heard oral arguments in , regarding the proper standard of review for patent claim constructions. Although de novo review of district court claim constructions has been the US Court of Appeals for the Federal Circuit's modus ...
 Intellectual Property Magazine1 month ago Par Pharmaceutical, Inc. v. TWi Pharmaceuticals, Inc. (Fed. Cir. 2014)  JD Supra3 weeks ago Supreme Court Corner: Q4 2014  JD Supra6 days ago Supreme Court 2014 Patent Preview  JD Supra1 week ago

Federal Circuit Rules Against Patent Declaratory Judgment Actions Before Biosimilar Application Is Filed

On December 5, 2014, the Federal Circuit issued its opinion in Sandoz Inc. v. Amgen Inc. et al. In a unanimous panel opinion (Judges Dyk, Taranto and Chen), the Court held that clinical trials initiated to support a possible subsequent filing of a ...
 JD Supra1 week ago Sandoz Was Disinvited to the Patent Dance: The Federal Circuit's First Interpretation of the BPCIA Will Have to Wait  JD Supra1 week ago Celltrion Healthcare Co. v. Kennedy Trust for Rhematology Research (S.D.N.Y. 2014); Hospira Inc. v. Janssen Biotech Inc. (S.D.N.Y. 2014)  JD Supra1 week ago Sandoz Inc. v. Amgen Inc. (Fed. Cir. 2014)  JD Supra2 weeks ago

FDA to Hold Advisory Committee Meeting on Proposed Biosimilar Version of Neupogen

body: The Food and Drug Administration (FDA) plans to hold an advisory committee meeting in January 2015 on Sandoz Inc.'s proposed biosimilar version of Amgen Inc.'s Neupogen (filgrastim) (79 Fed. Reg. 73,326). In July, FDA accepted Sandoz's ...
 AAPS Pharmceutica1 week ago Amgen : Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 73326) - Meeting  4 Traders1 week ago Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 73326) - Meeting  Pharmacy Choice1 week ago

Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New U.S. Headquarters

TRENTON, N.J., Nov. 6 -- The New Jersey Economic Development Authority issued the following news release: Showcasing New Jersey's continued ability to retain life-science companies, Lt. Governor Kim Guadagno today joined executives from Sandoz, ...
 Pharmaceutical & Medical Packaging News1 month ago Novartis : Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New U.S. Headquarters  4 Traders1 month ago

Sandoz launches generic version of anti-cancer drug in US

Sandoz Inc., the generic pharmaceutical division of Novartis, has launched the generic version of cyclophosphamide injection, USP, an anti-cancer drug in the US. Sandoz is launching cyclophosphamide injection, USP, through collaboration with Jiangsu ...
 Individual.com1 month ago

Harvard Bioscience elects new board member

Harvard Bioscience, Inc., a manufacturer of scientific instruments and apparatus, has elected Bertrand Loy to its board of directors. Mr Loy is President and CEO of Entegris Inc., a provider of yield-enhancing materials and solutions used in ...
 Individual.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less